316 related articles for article (PubMed ID: 19560215)
1. Acute neuroinflammation in Lewis rats - a model for acute multiple sclerosis relapses.
Schneider C; Schuetz G; Zollner TM
J Neuroimmunol; 2009 Aug; 213(1-2):84-90. PubMed ID: 19560215
[TBL] [Abstract][Full Text] [Related]
2. High-affinity NGF receptor in the rat spinal cord during acute and chronic phases of experimental autoimmune encephalomyelitis: a possible functional significance.
Oderfeld-Nowak B; Zaremba M; Lipkowski AW; Kwiatkowska-Patzer B; Triaca V; Aloe L
Arch Ital Biol; 2003 Mar; 141(2-3):103-16. PubMed ID: 12825322
[TBL] [Abstract][Full Text] [Related]
3. Induction of experimental autoimmune encephalomyelitis in Lewis rats by a viral peptide with limited homology to myelin basic protein.
Mao YS; Lu CZ; Wang X; Xiao BG
Exp Neurol; 2007 Aug; 206(2):231-9. PubMed ID: 17617406
[TBL] [Abstract][Full Text] [Related]
4. Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis.
Stanislaus R; Singh AK; Singh I
J Neurosci Res; 2001 Oct; 66(2):155-62. PubMed ID: 11592110
[TBL] [Abstract][Full Text] [Related]
5. Vitamin K2 ameliorates experimental autoimmune encephalomyelitis in Lewis rats.
Moriya M; Nakatsuji Y; Okuno T; Hamasaki T; Sawada M; Sakoda S
J Neuroimmunol; 2005 Dec; 170(1-2):11-20. PubMed ID: 16146654
[TBL] [Abstract][Full Text] [Related]
6. Possible role of ependymal proliferation in improving experimental allergic encephalomyelitis in Lewis rats.
Mohamed A; Yunus M; Hamadain E; Benghuzzi H
Biomed Sci Instrum; 2006; 42():405-9. PubMed ID: 16817642
[TBL] [Abstract][Full Text] [Related]
7. CD4 microglial expression correlates with spontaneous clinical improvement in the acute Lewis rat EAE model.
Almolda B; Costa M; Montoya M; González B; Castellano B
J Neuroimmunol; 2009 Apr; 209(1-2):65-80. PubMed ID: 19246105
[TBL] [Abstract][Full Text] [Related]
8. Regulation of gene expression associated with acute experimental autoimmune encephalomyelitis by Lovastatin.
Paintlia AS; Paintlia MK; Singh AK; Stanislaus R; Gilg AG; Barbosa E; Singh I
J Neurosci Res; 2004 Jul; 77(1):63-81. PubMed ID: 15197739
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment of acute EAE in Lewis rats with TNF-binding protein and interleukin-1 receptor antagonist.
Wiemann B; Van GY; Danilenko DM; Yan Q; Matheson C; Munyakazi L; Ogenstad S; Starnes CO
Exp Neurol; 1998 Feb; 149(2):455-63. PubMed ID: 9500957
[TBL] [Abstract][Full Text] [Related]
10. RDP58, a novel immunomodulatory peptide, ameliorates clinical signs of disease in the Lewis rat model of acute experimental autoimmune encephalomyelitis.
DeVry CG; Valdez M; Gao L; Wang J; Kotsch K; Volk HD; Bechmann I; Buelow R; Iyer S
J Neuroimmunol; 2004 Jul; 152(1-2):33-43. PubMed ID: 15223235
[TBL] [Abstract][Full Text] [Related]
11. Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis.
Karpus WJ; Ransohoff RM
J Immunol; 1998 Sep; 161(6):2667-71. PubMed ID: 9743321
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of VEGF-A in rat experimental autoimmune encephalomyelitis and in cerebrospinal fluid mononuclear cells from patients with multiple sclerosis.
Tham E; Gielen AW; Khademi M; Martin C; Piehl F
Scand J Immunol; 2006 Dec; 64(6):609-22. PubMed ID: 17083617
[TBL] [Abstract][Full Text] [Related]
13. A morphologic comparison of three experimental models of experimental allergic encephalomyelitis with multiple sclerosis.
Shaw CM; Alvord EC
Prog Clin Biol Res; 1984; 146():61-6. PubMed ID: 6201924
[No Abstract] [Full Text] [Related]
14. Melatonin ameliorates autoimmune encephalomyelitis through suppression of intercellular adhesion molecule-1.
Kang JC; Ahn M; Kim YS; Moon C; Lee Y; Wie MB; Lee YJ; Shin T
J Vet Sci; 2001 Aug; 2(2):85-9. PubMed ID: 14614276
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of monocyte chemotactic protein-1 and CC chemokine receptor 2 in the central nervous system is closely associated with relapse of autoimmune encephalomyelitis in Lewis rats.
Jee Y; Yoon WK; Okura Y; Tanuma N; Matsumoto Y
J Neuroimmunol; 2002 Jul; 128(1-2):49-57. PubMed ID: 12098510
[TBL] [Abstract][Full Text] [Related]
16. Experimental allergic encephalomyelitis animal models for analyzing features of multiple sclerosis.
Petry KG; Boullerne AI; Pousset F; Brochet B; Caillé JM; Dousset V
Pathol Biol (Paris); 2000 Feb; 48(1):47-53. PubMed ID: 10729911
[TBL] [Abstract][Full Text] [Related]
17. The use of digital technology to asses the severity of the Experimental Allergic Encephalomyelitis (EAE) spinal cord lesion.
Mohamed A; Tarhuni H; Dufan T; Benghuzzi H; Tucci M
Biomed Sci Instrum; 2004; 40():419-23. PubMed ID: 15133994
[TBL] [Abstract][Full Text] [Related]
18. [Experimental allergic encephalomyelitis as an animal model for multiple sclerosis].
Lukinović-Skudar V; Taradi SK; Andreis I; Zupancić V; Taradi M
Lijec Vjesn; 2001; 123(3-4):81-8. PubMed ID: 11488222
[TBL] [Abstract][Full Text] [Related]
19. Cytokine-induced enhancement of autoimmune inflammation in the brain and spinal cord: implications for multiple sclerosis.
Sun D; Newman TA; Perry VH; Weller RO
Neuropathol Appl Neurobiol; 2004 Aug; 30(4):374-84. PubMed ID: 15305983
[TBL] [Abstract][Full Text] [Related]
20. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
Vogt J; Paul F; Aktas O; Müller-Wielsch K; Dörr J; Dörr S; Bharathi BS; Glumm R; Schmitz C; Steinbusch H; Raine CS; Tsokos M; Nitsch R; Zipp F
Ann Neurol; 2009 Sep; 66(3):310-22. PubMed ID: 19798635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
